IP41-29: Molecular profiling of therapy-associated targets in metastatic urothelial carcinoma using the MODAPLEX platform: a step toward precision oncology
Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147A
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!